AAAAAA

   
Results: 1-23 |
Results: 23

Authors: OBRIEN SM HATFIELD ARW CRAIG PI WILLIAMS SP
Citation: Sm. Obrien et al., A 5-YEAR FOLLOW-UP OF SELF-EXPANDING METAL STENTS IN THE ENDOSCOPIC MANAGEMENT OF PATIENTS WITH BENIGN BILE-DUCT STRICTURES, European journal of gastroenterology & hepatology, 10(2), 1998, pp. 141-145

Authors: KANTARJIAN HM GILES FJ OBRIEN SM TALPAZ M
Citation: Hm. Kantarjian et al., CLINICAL COURSE AND THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA AND CHEMOTHERAPY, Hematology/oncology clinics of North America, 12(1), 1998, pp. 31

Authors: GILES FJ OBRIEN SM KEATING MJ
Citation: Fj. Giles et al., CHRONIC LYMPHOCYTIC-LEUKEMIA IN (RICHTERS) TRANSFORMATION, Seminars in oncology, 25(1), 1998, pp. 117-125

Authors: ROBBINS AH BORDEN MD WINDMILLER BS NIEZGODA M MARCUS LC OBRIEN SM KREINDEL SM MCGUILL MW DEMARIA A RUPPRECHT CE ROWELL S
Citation: Ah. Robbins et al., PREVENTION OF THE SPREAD OF RABIES TO WILDLIFE BY ORAL VACCINATION OFRACCOONS IN MASSACHUSETTS, Journal of the American Veterinary Medical Association, 213(10), 1998, pp. 1407-1412

Authors: RATAIN MJ SKOOG LA OBRIEN SM COOPER N SCHILSKY RL VOGELZANG NJ GERBER M NARANG PK NICOL SJ
Citation: Mj. Ratain et al., PHASE-I STUDY OF 3'-DEAMINO-3'-(2-METHOXY-4-MORPHOLINYL)DOXORUBICIN (FCE-23762, PNU-152243) ADMINISTERED ON A DAILY X3 SCHEDULE, Annals of oncology, 8(8), 1997, pp. 807-809

Authors: KANTARJIAN HM OBRIEN SM KEATING M BERAN M ESTEY E GIRALT S KORNBLAU S RIOS MB DEVOS D TALPAZ M
Citation: Hm. Kantarjian et al., RESULTS OF DECITABINE THERAPY IN THE ACCELERATED AND BLASTIC PHASES OF CHRONIC MYELOGENOUS LEUKEMIA, Leukemia, 11(10), 1997, pp. 1617-1620

Authors: KANTARJIAN HM OBRIEN SM ESTEY E GIRALT S BERAN M RIOS MB KEATING M DEVOS D TALPAZ M
Citation: Hm. Kantarjian et al., DECITABINE STUDIES IN CHRONIC AND ACUTE MYELOGENOUS LEUKEMIA, Leukemia, 11, 1997, pp. 35-36

Authors: FLEMING GF OBRIEN SM HOFFMAN PC VOKES EE VOGELZANG NJ SCHILSKY RL WAGGONER SE RATAIN MJ
Citation: Gf. Fleming et al., PHASE-I STUDY OF TREATMENT WITH ORAL 13-CIS-RETINOIC ACID, SUBCUTANEOUS INTERFERON ALFA-2A, CISPLATIN, AND 24-HOUR INFUSION 5-FLUOROURACIL LEUCOVORIN/, Cancer chemotherapy and pharmacology, 39(3), 1997, pp. 227-232

Authors: OBRIEN SM SLOANE RP THOMAS ORT DUNNILL P
Citation: Sm. Obrien et al., CHARACTERIZATION OF NONPOROUS MAGNETIC CHELATOR SUPPORTS AND THEIR USE TO RECOVER POLYHISTIDINE-TAILED T4 LYSOZYME FROM A CRUDE ESCHERICHIA-COLI EXTRACT, Journal of biotechnology, 54(1), 1997, pp. 53-67

Authors: OBRIEN SM CAMPBELL GR BURKE AF MAGUIRE OC ROWLANDS BJ FITZGERALD MX HEGARTY JE
Citation: Sm. Obrien et al., SERUM BILE-ACIDS AND URSODEOXYCHOLIC ACID TREATMENT IN CYSTIC FIBROSIS-RELATED LIVER-DISEASE, European journal of gastroenterology & hepatology, 8(5), 1996, pp. 477-483

Authors: LARSON RA MICK R SPIELBERGER RT OBRIEN SM RATAIN MJ
Citation: Ra. Larson et al., DOSE-ESCALATION TRIAL OF CLADRIBINE USING 5 DAILY INTRAVENOUS INFUSIONS IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES, Journal of clinical oncology, 14(1), 1996, pp. 188-195

Authors: OBRIEN SM THOMAS ORT DUNNILL P
Citation: Sm. Obrien et al., NONPOROUS MAGNETIC CHELATOR SUPPORTS FOR PROTEIN RECOVERY BY IMMOBILIZED METAL AFFINITY ADSORPTION, Journal of biotechnology, 50(1), 1996, pp. 13-25

Authors: SLOANE RP WARD JM OBRIEN SM THOMAS ORT DUNNILL P
Citation: Rp. Sloane et al., EXPRESSION AND PURIFICATION OF A RECOMBINANT METAL-BINDING T4 LYSOZYME FUSION PROTEIN, Journal of biotechnology, 49(1-3), 1996, pp. 231-238

Authors: FERNANDEZ MC WALTER FG KLOSTER JC OBRIEN SM BRADY LA VILLARIN A RUFFENACH SJ PROSNITZ EH SALMON JV
Citation: Mc. Fernandez et al., HEMODIALYSIS AND HEMOPERFUSION FOR TREATMENT OF VALPROIC ACID AND GABAPENTIN POISONING, Veterinary and human toxicology, 38(6), 1996, pp. 438-443

Authors: LILENBAUM RC RATAIN MJ MILLER AA HARGIS JB HOLLIS DR ROSNER GL OBRIEN SM BREWSTER L GREEN MR SCHILSKY RL
Citation: Rc. Lilenbaum et al., PHASE-I STUDY OF PACLITAXEL AND TOPOTECAN IN PATIENTS WITH ADVANCED TUMORS - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of clinical oncology, 13(9), 1995, pp. 2230-2237

Authors: PRETI HA HUH YO OBRIEN SM ANDREEFF M PIERCE ST KEATING M KANTARJIAN HM
Citation: Ha. Preti et al., MYELOID MARKERS IN ADULT ACUTE LYMPHOCYTIC-LEUKEMIA - CORRELATIONS WITH PATIENT AND DISEASE CHARACTERISTICS AND WITH PROGNOSIS, Cancer, 76(9), 1995, pp. 1564-1570

Authors: CORTES JE TALPAZ M BERAN M OBRIEN SM RIOS MB STASS S KANTARJIAN HM
Citation: Je. Cortes et al., PHILADELPHIA CHROMOSOME-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA WITH REARRANGEMENT OF THE BREAKPOINT CLUSTER REGION - LONG-TERM FOLLOW-UP RESULTS, Cancer, 75(2), 1995, pp. 464-470

Authors: CORTES J OBRIEN SM PIERCE S KEATING MJ FREIREICH EJ KANTARJIAN HM
Citation: J. Cortes et al., THE VALUE OF HIGH-DOSE SYSTEMIC CHEMOTHERAPY AND INTRATHECAL THERAPY FOR CENTRAL-NERVOUS-SYSTEM PROPHYLAXIS IN DIFFERENT RISK GROUPS OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 86(6), 1995, pp. 2091-2097

Authors: FLEMING GF RATAIN MJ OBRIEN SM SCHILSKY RL HOFFMAN PC RICHARDS JM VOGELZANG NJ KASUNIC DA EARHART RH
Citation: Gf. Fleming et al., PHASE-I STUDY OF ADOZELESIN ADMINISTERED BY 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION, Journal of the National Cancer Institute, 86(5), 1994, pp. 368-372

Authors: KOBAYASHI K VOGELZANG NJ OBRIEN SM SCHILSKY RL VOKES EE RATAIN MJ
Citation: K. Kobayashi et al., A PHASE-I STUDY OF INTERMITTENT INFUSION CLADRIBINE IN PATIENTS WITH SOLID TUMORS, Cancer, 74(1), 1994, pp. 168-173

Authors: VOKES EE OBRIEN SM VOGELZANG NJ SCHILSKY RL RATAIN MJ
Citation: Ee. Vokes et al., 5-DAY INFUSIONAL FLUORODEOXYURIDINE WITH ORAL LEUCOVORIN AND ESCALATING DOSES OF INTERFERON-ALPHA-2B - A PHASE-I STUDY, Cancer chemotherapy and pharmacology, 32(5), 1993, pp. 347-352

Authors: MEDYCKYJSCOTT DJ NEWMAN IA OBRIEN SM
Citation: Dj. Medyckyjscott et al., GENIE - A GLOBAL ENVIRONMENTAL NETWORK FOR INFORMATION EXCHANGE, Journal of information science, 19(5), 1993, pp. 403-406

Authors: SAMUELS BL MICK R VOGELZANG NJ WILLIAMS SF SCHILSKY RL SAFA AR OBRIEN SM RATAIN MJ
Citation: Bl. Samuels et al., MODULATION OF VINBLASTINE RESISTANCE WITH CYCLOSPORINE - A PHASE-I STUDY, Clinical pharmacology and therapeutics, 54(4), 1993, pp. 421-429
Risultati: 1-23 |